Multiple Sclerosis News Today

Skip to content
  • Home
  • Forums
  • HCP Portal
  • Columns
    • Archived Columns
      • MSunderstood Millennial
      • Engaging Thoughts – a Column by Laura Kolaczkowski
      • Faith of the Mustard Seed
      • You’ve Got Some Nerves
      • Make Change Happen
      • Making a Difference
      • MS in Moderation
      • MS in Motion – a Column by Mike Knight
    • Silver Linings
    • The MS Wire
    • Patiently Awakened
    • A Life in Letters
    • DISabled to ENabled
    • Fall Down, Get Up Again
  • 31 Days of MS
  • ACTRIMS 2021
  • Categories
    • FAQs
    • Health Insights
    • Social Clips
    • RRMS
    • SPMS
    • PPMS
    • Clinical Trials
    • National MS Society
  • What is MS?
    • Causes
    • MS Types
      • Clinically Isolated Syndrome (CIS)
      • Primary Progressive Multiple Sclerosis (PPMS)
      • Relapsing-Remitting Multiple Sclerosis (RRMS)
      • Secondary Progressive Multiple Sclerosis (SPMS)
    • Autoimmune Disease
    • Prognosis and Life Expectancy
    • MS vs. ALS: How Do They Differ?
    • Statistics
    • Healthy Living
      • Physical Exercise
      • Diet & Nutrition
        • Swank Diet
        • McDougall Diet
        • Paleo Diet
        • Mediterranean Diet
        • Gluten-Free Diet
        • Foods to Eat and Avoid
    • Pseudobulbar Affect in Multiple Sclerosis
    • Symptoms
      • Dizziness and Vertigo
      • Early Signs
      • Fatigue
      • Flare-ups
      • Bladder Issues
        • Bladder Problems and MS
        • Bladder Infection
        • Bladder Spasms
        • Neurogenic Bladder
        • Urinary Retention
        • Neurogenic Detrusor Overactivity and MS
        • Overactive Bladder
        • Urinary Incontinence and MS
      • Bowel Incontinence
      • Depression
      • Pain
      • Dysesthesia
      • Heat Intolerance
      • Lhermitte’s sign
      • Sexual Dysfunctions
      • Spasticity
      • The MS hug
      • Uhthoff’s Syndrome
      • Vision Problems
        • Optic Neuritis in Multiple Sclerosis
    • Diagnosis
      • Guidelines for MS diagnosis: McDonald Criteria
      • Magnetic Resonance Imaging (MRI) and MS Diagnosis
      • Evoked Potential (EP) Test and Multiple Sclerosis Diagnosis
      • Spinal Tap Test and Multiple Sclerosis Diagnosis
    • Manage MS Symptoms
      • Fatigue
        • Amantadine For Fatigue
        • Provigil (modafinil)
        • Prozac (fluoxetine)
        • Antivert (meclizine) for Vertigo and Dizziness
      • Bladder Dysfunction
        • Botox (onabotulinumtoxinA)
        • DDAVP Nasal Spray
        • Detrol (tolterodine)
        • Ditropan (oxybutynin) & Ditropan XL
        • Enablex (darifenacin)
        • Flomax (tamsulosin)
        • Hytrin (terazosin)
        • Minipress (prazosin)
        • Oxytrol (oxybutynin)
        • Propantheline
        • Sanctura (trospium chloride)
        • Tofranil (imipramine)
        • Vesicare (solifenacin succinate)
      • Bowel Dysfunction
        • Colace (docusate) for Constipation
        • Dulcolax (bisacodyl)
        • Enemeez (docusate stool softener laxative)
        • Fleet Enema (sodium phosphate) for Constipation
        • Metamucil (psyllium) for Constipation
        • Mineral Oil for Constipation
        • Phillips Milk of Magnesia (magnesium hydroxide) for Constipation
        • Sani-Supp Suppository (glycerin) for Constipation
      • Depression
        • Cymbalta (duloxetine hydrochloride) for Depression
        • Effexor XR (venlafaxine) for Depression
        • Nuedexta (dextromethorphan + quinidine) for PBA
        • Paxil (paroxetine) for Depression
        • Prozac (fluoxetine) for Depression
        • Wellbutrin (bupropion) for Depression
        • Zoloft (sertraline) for Depression
      • Infections
        • Cipro (ciprofloxacin) for UTIs
        • Hiprex (methenamine) for UTIs
        • Macrodantin (nitrofurantoin) for UTIs
      • Muscle Spasms
        • Dantrium (dantrolene)
        • Botox (onabotulinumtoxinA)
        • Gablofen (baclofen – intrathecal)
        • Klonopin – Rivotril – Syn-Clonazepam (clonazepam)
        • Lioresal (baclofen)
        • Nydrazid / Laniazid (isoniazid)
        • Valium (diazepam)
        • Zanaflex (tizanidine)
      • Tremor
        • Inderal (Propranolol)
        • Deep Brain Stimulation
      • Pain
        • Amitriptyline for Pain Management
        • Atarax (hydroxyzine) for Itching and Burning
        • Deltasone (prednisone) for Relapse Management
        • Dilantin (phenytoin) for Pain Management
        • Klonopin (clonazepam) for Pain Management
        • Neurontin (gabapentin) for Pain Management
        • Pamelor; Aventyl (nortriptyline) for Pain Managemen
        • Pyridium (phenazopyridine) for UTI Pain
        • Tegetrol (carbamazepine) for Pain Management
      • Sexual Dysfunction
        • Cialis (tadalafil) for Erectile Dysfunction
        • MUSE (alprostadil) for Erectile Dysfunction
        • Levitra (vardenafil) for Erectile Dysfunction
        • Papaverine for Erectile Dysfunction
        • Viagra for Erectile Dysfunction & Female Sexual Arousal Disorder
  • Treatments
    • Aubagio
    • Avonex
    • Betaseron
    • Copaxone
    • Decadron
    • Extavia
    • Gilenya
    • Glatopa
    • Kesimpta (Ofatumumab)
    • Lemtrada
    • Mavenclad
    • Mayzent
    • Novantrone
    • Ocrevus
    • Plegridy
    • Rebif (Interferon beta-1a)
    • Solu-Medrol
    • Vumerity
    • Tecfidera
    • Tysabri (Natalizumab)
    • Zeposia (Ozanimod)
    • Zinbryta (Daclizumab)
    • RRMS Therapies
    • Stem Cell Therapy
      • aHSCT – Autologous Hemopoietic Stem Cell Transplantation in MS
      • Stem Cell Clinical Trials and MS
        • Mesenchymal Stem Cell (MSCT) Clinical Trials
        • Neuron Stem Cell (NSC) Clinical Trials
      • Different Types of Stem Cells
      • How are Stem Cells Regulated?
    • Experimental Treatments
      • AP-1
      • Midamor (Amiloride) for PPMS and SPMS
      • Amiselimod (MT-1303)
      • Anti-LINGO-1 / BIIB033 / Opicinumab
      • APD334
      • ATL1102
      • ATX-MS-1467
      • BN201
      • CNM-Au8
      • Dalazatide (Formerly ShK-186)
      • Dysport (abobotulinumtoxin A) for Overactive Bladder
      • CTP-354
      • Evobrutinib
      • GIFT-15
      • GLX1112
      • GNbAC1
      • Ibudilast (MN-166)
      • IkT-001Pro
      • Laquinimod (Nerventra, ABR-215062)
      • Lisinopril
      • Lipoic Acid
      • Masitinib (AB1010)
      • Minocycline
      • MD1003
      • MEDI-551
      • MIS416 for SPMS
      • NDC-1308
      • PDA-001
      • Ponesimod
      • Raltegravir (isentress)
      • Raxone (Idebenone) for PPMS
      • rHIgM22
      • RHB-104
      • Riluzole for PPMS and SPMS
      • Rituximab
      • RPI-78M
      • RTL1000
      • Simvastatin for SPMS
      • Tcelna
      • Vatelizumab (GBR 500)
      • Vitamin D
      • Zenapax
    • Assistive Devices for Multiple Sclerosis
      • ReWalk for Multiple Sclerosis
      • SafeGait 360 Balance and Mobility Trainer
      • External Urethral Barrier
  • Multimedia
    • MS Podcast
    • Flash Briefings
  • COVID-19 Info
    • COVID-19 Updates

What can we help you find today?

MSAA Marks 50th Anniversary with Benefit Evening, New Logo and More

February 3, 2020February 3, 2020
Marisa Wexler MSby Marisa Wexler MS

In News.

MSAA Marks 50th Anniversary with Benefit Evening, New Logo and More

Click here to subscribe to the Multiple Sclerosis News Today Newsletter!

0
(0)

The Multiple Sclerosis Association of America (MSAA) is celebrating 50 years of work and dedication to improving the lives of people affected by multiple sclerosis (MS). Some changes are underway and initiatives being launched to commemorate this milestone.

MSAA, a nonprofit organization founded in 1970, aims to provide services and support to people with MS, as well as their loved ones and care partners.

A new logo was unveiled to commemorate the anniversary. According to a MSAA press release, this “warm and welcoming icon” is “designed to appear as an abstract of people gathering,” with the intent of conveying ideas of communication, connection, support, and hope. A special version of the logo, specific to the 50th anniversary was also created.

The organization also redesigned its website homepage to allow more streamline access to important information. A special 50th anniversary page was created, which includes “word clouds” about what the MSAA does, and about coping with MS.

MSAA is also launching a social media campaign, with plans “to post 50 photos of the MS community in 50 weeks.” In addition, social media users are encouraged to share a photo on their account, along with a caption explaining why they chose to support the MS community. Social media users can tag the MSAA, using the hashtag: #MSAA50.

Finally, the group is planning a 50th anniversary Improving Lives Benefit event, which will be held on Saturday, April 4, in Jersey City, New Jersey. The evening will include a cocktail reception and dinner, as well as a performance by the classic rock group The Hit Men. There will also be a presentation reflecting on the history of the MSAA.

Tickets to the benefit can be purchased here. All funds raised will support MSAA’s free services and programs for the MS community.

Over the years, MSAA has developed several initiatives to support the MS community. These include a MS-focused magazine, The Motivator; a program to help people with MS making treatment decisions, called S.E.A.R.C.H.; a mobile phone application, My MS Manager, to help track disease activity and manage clinical information; educational programs across the country; and the online support forum, My MSAA Community.

  • Author Details
Marisa Wexler MS
Marisa holds an MS in Cellular and Molecular Pathology from the University of Pittsburgh, where she studied novel genetic drivers of ovarian cancer. She specializes in cancer biology, immunology, and genetics. Marisa began working with BioNews in 2018, and has written about science and health for SelfHacked and the Genetics Society of America. She also writes/composes musicals and coaches the University of Pittsburgh fencing club.
Patricia Silva PhD
Total Posts: 1,053
Patrícia holds her PhD in Medical Microbiology and Infectious Diseases from the Leiden University Medical Center in Leiden, The Netherlands. She has studied Applied Biology at Universidade do Minho and was a postdoctoral research fellow at Instituto de Medicina Molecular in Lisbon, Portugal. Her work has been focused on molecular genetic traits of infectious agents such as viruses and parasites.
×
Marisa Wexler MS
Marisa holds an MS in Cellular and Molecular Pathology from the University of Pittsburgh, where she studied novel genetic drivers of ovarian cancer. She specializes in cancer biology, immunology, and genetics. Marisa began working with BioNews in 2018, and has written about science and health for SelfHacked and the Genetics Society of America. She also writes/composes musicals and coaches the University of Pittsburgh fencing club.
Latest Posts
  • socioeconomically disadvantaged MS patients
  • fatigue
  • evobrutinib trials
  • Sensoready autoinjector pen
Print This Page

How useful was this post?

Click on a star to rate it!

Average rating 0 / 5. Vote count: 0

No votes so far! Be the first to rate this post.

As you found this post useful...

Follow us on social media!

We are sorry that this post was not useful for you!

Let us improve this post!

Tell us how we can improve this post?

Tagged 50th anniversary, campaign, logo, MSAA, Multiple Sclerosis Association of America, social media, support.

Post navigation

coronavirusPrevious: Here’s My ‘Veganuary’ Report
MSVirtual2020Next:Interaction Between Different Immune Cells May Lead to New MS Therapies, Study Suggests

Featured Posts

Top 10 Multiple Sclerosis Stories of 2020

December 29, 2020

top 10 stories

Ocrevus Targets Pro-inflammatory T-cells, Not Just B-cells, in PPMS, Study Finds

January 19, 2021

Ocrevus

#ACTRIMS2020 – Vitamin D at High Dose Can Worsen MS, Early Study Says

March 2, 2020

bile acid supplements

MS News Today

BioNews Services, LLC
3 W Garden St
Suite 700
Pensacola, FL 32502
Email: [email protected]
Phone: +1-800-936-1363
  • Publishing Team
  • Leadership
  • Our Values
  • Corrections Policy
  • Write For Us – Become a Columnist
  • Contact Us
  • Privacy Policy
  • Terms of Service
  • Advertise
  • Disable Notifications
  • Site Map

Disclaimer:

Multiple Sclerosis News Today is strictly a news and information website about the disease. It does not provide medical advice, diagnosis or treatment. This content is not intended to be a substitute for professional medical advice, diagnosis, or treatment. Always seek the advice of your physician or other qualified health provider with any questions you may have regarding a medical condition. Never disregard professional medical advice or delay in seeking it because of something you have read on this website.
Copyright © 2013-2021 All rights reserved n